Vol 13, Issue 5 (Sep-Oct), 2021

Published: 07-09-2021

Review Article(s)

SUPPORTIVE THERAPY: AN OPTION TO ENHANCE HOST IMMUNITY AGAINST COVID-19

AMRUTHA V. U., ARYA G. K., ARYA M., VANI VIJAY, AKSHAYA KRISHNA, ABHINANDH B., ANAND CHANDRAN, SREEJA C. NAIR

1-9
A REVIEW ON COVID-19 PANDEMIC A GLOBAL THREAT-CURRENT STATUS AND CHALLENGES AND PREVENTIVE STRATEGIES

SUNITHA SUKUMARAN, S. SATHIANARAYANAN

10-14
APPLYING NANOPARTICLES FOR TREATING GIARDIA INFECTION: A SYSTEMATIC REVIEW

HAMDAN I. ALMOHAMMED, AISHAH E. ALBALAWI, HADEEL AL SADOUN, NAVID BAKHTIARI, MORTEZA AMRAEI, ALI MOGHADDAM, GHAIDAA RAHEEM LATEEF AL-AWSI

15-19
CHARACTERISTICS AND ANALYTICAL METHODS OF MANNITOL: AN UPDATE

ALANKAR SHRIVASTAVA, SANJAY SHARMA, MONIKA KAURAV, ABHISHEK SHARMA

20-32
NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS

SRI HARTATI YULIANI

33-43
PHARMACEUTICAL AND BIOPHARMACEUTICAL ASPECTS OF QUANTUM DOTS-AN OVERVIEW

SADDAM C. SHAIKH, SHWETA G. SABOO, PRASHANT S. TANDALE, FAHIM S. MEMON, SHARAD D. TAYADE, M. AKIFUL HAQUE, SHARUK L. KHAN

44-53
IMPACT OF COVID-19 ON MULTIPLE BODY ORGAN FAILURE: A REVIEW

AYA YASEEN MAHMOOD ALABDALI, SASIKALA CHINNAPPAN, BASMA M. ABD RAZIK, MOGANA R., SHAIK IBRAHIM KHALIVULLA, RAHMAN H., LAITH H. SAMEIN

54-59

Original Article(s)

FORMULATION AND EVALUATION OF FIXED-DOSE COMBINATION OF BILAYER TABLETS OF ATAZANAVIR SULFATE AND RITONAVIR 300 MG/100 MG

JONNA SANKARAIAH, NEERAJ SHARMA, MOHD JAVED NAIM

60-72
ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDIES BY RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ANDROGRAPHOLIDE AND CURCUMIN IN CO-ENCAPSULATED NANOSTRUCTURED LIPID CARRIER DRUG DELIVERY SYSTEM

ASIT KUMAR DE, TANMOY BERA

73-86
CENTRAL COMPOSITE DESIGN FOR FORMULATION AND OPTIMIZATION OF LONG-ACTING INJECTABLE (LAI) MICROSPHERES OF PALIPERIDONE PALMITATE

SANDIP MALI, NISHANT OZA

87-98
FORMULATION, IN VITRO, AND IN VIVO EVALUATION OF TASTE-MASKED ORAL DISINTEGRATING TABLETS OF FEXOFENADINE HYDROCHLORIDE USING SEMISYNTHETIC AND NATURAL SUPERDISINTEGRANTS

NAGADANI SWARNALATHA, VIDYAVATHI MARAVAJHALA

99-108
FORMULATION AND OPTIMIZATION AND IN VITRO CHARACTERIZATION OF OLANZAPINE LIPOSOME

G. NETHRA VANI, M. ALAGUSUNDARAM, K. B. CHANDRASEKAR

109-114
DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RELATED SUBSTANCES OF TRANDOLAPRIL BY RP-HPLC AND ITS DEGRADATION

CHALLA SUDHEER REDDY, B. TIRUMALESWARA RAO

115-121
AN OVERVIEW OF EPIGENETIC DRUGS, AND THEIR VIRTUAL SCREENING STUDY RETRIEVED FROM ZINC DATABASE ALONG WITH AN AUTODOCK STUDY OF THE BEST INHIBITOR

EIICHI AKAHO

122-131
FORMULATION AND QBD BASED OPTIMIZATION OF METHOTREXATE-LOADED SOLID LIPID NANOPARTICLES FOR AN EFFECTIVE ANTI-CANCER TREATMENT

CHAITALI SURVE, RUCHI SINGH, ANANYA BANERJEE, SRINIVAS PATNAIK, SUPRIYA SHIDHAYE

132-143
XYLOGLUCAN CONJUGATED FUNCTIONALIZED GRAPHENE OXIDE AS A NANO CARRIER SYSTEM FOR pH RESPONSIVE TARGETED DRUG DELIVERY OF FUCOIDAN

K. SONIA, D. RAJESH, S. ARUNA SHARMILI, K. S. MEENA

144-153
STABILITY INDICATING AND COST-EFFECTIVE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SOTORASIB BY USING RP-HPLC

SUBBA RAO YARLAGADDA, SUBBA RAO MANNAM, BABY PADMINI JAMPANI

154-159
QUALITY BY DESIGN (QBD) AS A TOOL FOR THE OPTIMIZATION OF INDOMETHACIN FREEZE-DRIED SUBLINGUAL TABLETS: IN VITRO AND IN VIVO EVALUATION

MERVAT SHAFIK IBRAHIM, NIHAL MOHAMED ELMAHDY ELSAYYAD, ABEER SALAMA, SHEREEN H. NOSHI

160-171
DEVELOPMENT AND PHARMACOKINETICS OF CURCUMIN LOADED BETA CAROTENE NANOPARTICLES IN RATS

RAVIKANTH CHINTHALA, SURYA SATYANARAYANA SINGH

172-176
NEW STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF CAPECITABINE AND DOCETAXEL IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC

NEEHARIKA TIRUMALASETTY, RAMCHANDRAN D.

177-182
QBD APPROACH TO ANALYTICAL METHOD DEVELOPMENT AND ITS VALIDATION FOR ESTIMATION OF LENVATINIB IN BULK AND PHARMACEUTICAL FORMULATION

SACHIN A. BABAR, SUDHAKAR L. PADWAL

183-188
TOPICAL DELIVERY OF QUERCETIN LOADED TRANSFERSOMES FOR WOUND TREATMENT: IN VITRO AND IN VIVO EVALUATION

MARWA ABDALLAH, DEMIANA I. NESEEM, OMAIMA N. ELGAZAYERLY, ALY A. ABDELBARY

189-197
BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF AVELUMAB, AXITINIB AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RABBIT PLASMA BY USING LCMS/MS

SYED RAFI, KANTIPUDI RAMBABU

198-204
DEVELOPMENT OF RIVASTIGMINE LOADED SELF ASSEMBLED NANOSTRUCTURES OF NONIONIC SURFACTANTS FOR BRAIN DELIVERY

SARASWATHI T. S., MOTHILAL M.

205-215
NEW VALIDATED METHOD FOR THE ESTIMATION OF ALLANTOIN AND PERMETHRIN USIGN RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORM

MADHAVI S., CHALLA SUDHEER REDDY, B. TIRUMALESWARA RAO

216-222
NOVEL FLOATING AGENT SACCHAROMYCES BOULARDII FORMULATION BASED FLOATING DRUG DELIVERY SYSTEM

SUVARNA CHITTAM, ASHOK BHOSALE

223-229
BIOEQUIVALENCE EVALUATION OF ORALLY DISINTEGRATING STRIPS OF RIZATRIPTAN IN MALE VOLUNTEERS UNDER FASTING CONDITIONS

NIDHI SAPKAL, ANWAR DAUD, MINAL BONDE, MANGESH GAWANDE, NILAMBARI GURAV

230-235
STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF MITOMYCIN AND FLUOROURACIL BY USING UPLC

GUNTURU RAVITEJA, KANTIPUDI RAMBABU

236-243
OPTIMIZATION OF STARCH GLYCOLATE AS NOVEL SUPERDISINTEGRANT IN THE FORMULATION OF GLIPIZIDE FAST DISSOLVING TABLETS THROUGH 23FACTORIAL DESIGN

A. HARI OM PRAKASH RAO, R. SANTOSH KUMAR, SHAMBHAVI KANDUKURI, M. RAMYA

244-251
MITRAGYNINE PERCENTAGES OF VARIOUS KRATOM VARIANTS SEIZED IN INDONESIA: A QUANTITATIVE ANALYSIS USING LIQUID CHROMATOGRAPHY-PHOTO DIODE ARRAY DETECTOR

TANTI, CHRISTIEN ANDRIYANI LALANGI, ERI ARFIYANI, WIDIANTI NINGTIAS, ERLANA NINDYA MAULIDA

252-256
BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF DECITABINE AND CEDAZURIDINE IN HUMAN PLASMA USING LC-MS/MS

SAI PRUDHVI N., VENKATESWARLU B. S., KUMUDHAVALLI M. V., MURUGANANTHAM V.

257-262
FABRICATION AND CHARACTERIZATION OF FAST DISSOLVING FILMS OF ECLIPTA PROSTRATE LEAVES EXTRACT TO TREAT MOUTH ULCERS

MANIKIRAN S. S., NAGAM SANTHI PRIYA, B. AUBINE MOLLY, LAKSHMI PRASANTHI NORI

263-271
EVOLUTIONARY RELATIONSHIP AND REPURPOSING OF SARS INHIBITORS AGAINST SURFACE GLYCOPROTEIN OF SARS-COV-2

PRIYANKA RAJBHAR, DIKSHANT SINGH, RUKHSAR FATIMA, RUCHI YADAV

272-279
BIOCOMPUTATIONAL AND PHARMACOLOGICAL ANALYSIS OF PHYTOCHEMICALS FROM ZINGIBER OFFICINALE (GINGER), ALLIUM SATIVUM (GARLIC), AND MURRAYAKOENIGII (CURRY LEAF) IN CONTRAST TO TYPE 2-DIABETES

RATUL BHOWMIK, SHUBHAM ROY, SOUNOK SENGUPTA, SAMEER SHARMA

280-286
FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF PANTOPRAZOLE SODIUM

M. R. SHIVALINGAM, ARUL BALASUBRAMANIAN, KOTHAI RAMALINGAM

287-291
STABILITY INDICATIVE AND COST EFFECTIVE ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FENOFIBRIC ACID AND PITAVASTATIN BY USING RP-HPLC

D. RAMCHANDRAN, ANITHA KETHIPALLI, MANNAM KRISHNAMURTHY

292-297
DEVELOPMENT OF HPLC STABILITY DEMONSTRATING METHODOLOGY FOR QUANTIFYING AZELNIDIPINE AND TELMISARTAN IN TABLETS AND BULK TYPES: VALIDATION FOLLOWING ICH DIRECTIVES

KRISHNAPHANISRI PONNEKANTI, K. SUNITHA

298-305
FORMULATION AND CHARACTERIZATION OF FLOATING TABLET DOSAGE FORM OF DUAL DELIVERY OF DRUG CURCUMIN AND BERBERINE HYDROCHLORIDE USING SIMULTANEOUS ESTIMATION BY UV SPECTROSCOPY

KOLLOL KUMAR MAJUMDER, MANISH KUMAR, RAKESH PAHWA, AVNEET KAUR LAMBA, RAVI SHANKAR, ABHISHEK TIWARI, VARSHA TIWARI, RISHABH

306-310
FORMULATION AND OPTIMIZATION OF NIFEDIPINE LOADED NANOCARRIERS

ASHWINI JADHAV, BINOY VARGHESE CHERIYAN

311-317
FORMULATION, OPTIMIZATION, AND IN VITRO CHARACTERIZATION OF DASATINIB LOADED POLYMERIC NANOCARRIERS TO EXTEND THE RELEASE OF THE MODEL DRUG

SANDEEP KUMAR REDDY ADENA, KASI VISWANADH MATTE, RAMOJI KOSURU

318-330
INHIBITION OF GASTRIC DEGRADATION OF OMEPRAZOLE USING A pH-SENSITIVE POLYMER AS A BINDER IN TABLET FORMULATION

EMMANUEL O. OLORUNSOLA, IMO E. UDOH, STEPHEN O. MAJEKODUNMI, INIOBONG J. ODIONG, UWAKMFON O. EBONG

331-335
THE EVALUATION OF ACTIVITY AND STABILITY OF ISOLATED BROMELAIN FROM PINEAPPLE CORES (ANANAS COMOSUS [L.] MERR) AND IN VITRO PENETRATION TEST OF NANOEMULSION TOPICAL BASE

AINUR ROHMAH, HEGI ADI PRABOWO, SISWATI SETIASIH, SRI HANDAYANI, MAHDI JUFRI, SUMI HUDIYONO

336-342
FORMULATION AND EVALUATION OF METFORMIN HYDROCHLORIDE AND GLICLAZIDE SUSTAINED RELEASE BILAYER TABLETS: A COMBINATION THERAPY IN MANAGEMENT OF DIABETES

RAJESWARI ALETI, SRINIVASA RAO BARATAM, BANGARUTHALLI JAGIRAPU, SRAVYA KUDAMALA

343-350
FORMULATION AND EVALUATION OF TOPICAL NANOEMULGEL OF METHOTREXATE FOR RHEUMATOID ARTHRITIS

SAHELI DAS, SHARADHA M., M. P. VENKATESH, SUBHASHREE SAHOO, JOGABRATA TRIPATHY, D. V. GOWDA

351-357
VALIDATED AND QUANTIFIED STABILITY INDICATING STRESS DEGRADATION STUDY OF ORAL ANTI-DIABETIC AGENT CANAGLIFLOZIN BY RP-HPLC METHOD

ARULSELVAN MURUGESAN, MUKTHINUTHALAPATI MATHRUSRI ANNAPURNA

358-363
A RIPPLE EFFECT OF COVID-19 PANDEMIC ON SHORTAGE OF MEDICINAL PRODUCTS AND ITS IMPACT ON PATIENT CARE

BIPLAB KUMAR DEY, EFFICIENCY MYRSING, RUHUL AMIN, FARUK ALAM, MIZANUR RAHMAN, PAL GOGOI, TAHMINA AFROZ

364-370

Short Communication(s)

ALTERATION OF PHARMACOKINETIC PARAMETERS OF PROTON PUMP INHIBITORS USING TRANSDERMAL DRUG DELIVERY SYSTEM

M. R. SHIVALINGAM, ARUL BALASUBRAMANIAN, KOTHAI RAMALINGAM

371-375